These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34993416)

  • 1. Repurposable drugs for SARS-CoV-2 and influenza sepsis with scRNA-seq data targeting post-transcription modifications.
    Wang Z; Guo K; Gao P; Pu Q; Li C; Hur J; Wu M
    Precis Clin Med; 2021 Dec; 4(4):215-230. PubMed ID: 34993416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Repurposable Drugs and Adverse Drug Reactions for Various Courses of COVID-19 Based on Single-Cell RNA Sequencing Data.
    Wang Z; Guo K; Gao P; Pu Q; Wu M; Li C; Hur J
    ArXiv; 2020 May; ():. PubMed ID: 33299905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploiting cheminformatic and machine learning to navigate the available chemical space of potential small molecule inhibitors of SARS-CoV-2.
    Kumar A; Loharch S; Kumar S; Ringe RP; Parkesh R
    Comput Struct Biotechnol J; 2021; 19():424-438. PubMed ID: 33391634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.
    Ahmed FF; Reza MS; Sarker MS; Islam MS; Mosharaf MP; Hasan S; Mollah MNH
    PLoS One; 2022; 17(4):e0266124. PubMed ID: 35390032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening.
    Chtita S; Belhassan A; Aouidate A; Belaidi S; Bouachrine M; Lakhlifi T
    Comb Chem High Throughput Screen; 2021; 24(3):441-454. PubMed ID: 32748740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Strategies of Antiviral Drug Discovery for COVID-19.
    Mei M; Tan X
    Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19.
    Islam T; Rahman MR; Aydin B; Beklen H; Arga KY; Shahjaman M
    Eur J Pharmacol; 2020 Nov; 887():173594. PubMed ID: 32971089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the PHENotype SIMulator for rapid identification of potential candidates in effective COVID-19 drug repurposing.
    Maria NI; Rapicavoli RV; Alaimo S; Bischof E; Stasuzzo A; Broek JAC; Pulvirenti A; Mishra B; Duits AJ; Ferro A;
    Heliyon; 2023 Mar; 9(3):e14115. PubMed ID: 36911878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triazavirin might be the new hope to fight Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Hudecová IMJČGKMPL
    Ceska Slov Farm; 2021; 70(1):18-25. PubMed ID: 34237949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp12/7/8 RNA-dependent RNA polymerase.
    Bertolin AP; Weissmann F; Zeng J; Posse V; Milligan JC; Canal B; Ulferts R; Wu M; Drury LS; Howell M; Beale R; Diffley JFX
    Biochem J; 2021 Jul; 478(13):2425-2443. PubMed ID: 34198323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repurposing Didanosine as a Potential Treatment for COVID-19 Using Single-Cell RNA Sequencing Data.
    Alakwaa FM
    mSystems; 2020 Apr; 5(2):. PubMed ID: 32291351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Coronavirus Network Explorer: mining a large-scale knowledge graph for effects of SARS-CoV-2 on host cell function.
    Krämer A; Billaud JN; Tugendreich S; Shiffman D; Jones M; Green J
    BMC Bioinformatics; 2021 May; 22(1):229. PubMed ID: 33941085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2.
    Zhou Y; Hou Y; Shen J; Huang Y; Martin W; Cheng F
    Cell Discov; 2020; 6():14. PubMed ID: 32194980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering SARS CoV-2-associated pathways from RNA sequencing data of COVID-19-infected A549 cells and potential therapeutics using in silico methods.
    Natesan Pushparaj P; Damiati LA; Denetiu I; Bakhashab S; Asif M; Hussain A; Ahmed S; Hamdard MH; Rasool M
    Medicine (Baltimore); 2022 Sep; 101(35):e29554. PubMed ID: 36107502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host transcriptome-guided drug repurposing for COVID-19 treatment: a meta-analysis based approach.
    Loganathan T; Ramachandran S; Shankaran P; Nagarajan D; Mohan S S
    PeerJ; 2020; 8():e9357. PubMed ID: 32566414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.
    Fiscon G; Conte F; Farina L; Paci P
    PLoS Comput Biol; 2021 Feb; 17(2):e1008686. PubMed ID: 33544720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A signaling pathway-driven bioinformatics pipeline for predicting therapeutics against emerging infectious diseases.
    Scott TM; Jensen S; Pickett BE
    F1000Res; 2021; 10():330. PubMed ID: 34868553
    [No Abstract]   [Full Text] [Related]  

  • 20. Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications.
    Ting CT; Chen BS
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.